Significant Change in Predicted Risk of Biochemical Recurrence After Radical Prostatectomy More Common in Black Than in White Men

被引:4
|
作者
Laudano, Melissa A. [1 ]
Badani, Ketan K.
McCann, Tara R.
Mann, Mark J.
Ritch, Chad
Desai, Manisha
Benson, Mitchell C.
McKiernan, James M.
机构
[1] Columbia Univ, Med Ctr, Dept Urol, New York, NY 10032 USA
关键词
PREOPERATIVE NOMOGRAM; DISEASE RECURRENCE; CANCER RECURRENCE; VALIDATION;
D O I
10.1016/j.urology.2008.10.075
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
OBJECTIVES To examine by race how frequently the data after radical prostatectomy translates into a Substantial change in prognosis. Many nomograms exist to predict the survival outcomes using the pretreatment clinical parameters and post-treatment pathologic parameters. Race might be an important factor affecting their predictive ability. METHODS Kattan nomograms were used to calculate the pretreatment and post-radical prostatectomy 5-year progression-free probability for each patient. The difference between the nomogram scores was used to divide the patients into 3 groups. A decrease in probability of >= 15 percentage points was classified as a significant increase in the probability of recurrence, an increase of >= 15 points was classified as a significant decrease in the probability of recurrence, and an absolute change of 15 points was considered no significant change. RESULTS The data from 1709 (132 black and 1577 white) men were analyzed. Among the black men, 26.5% had an increase in the probability of recurrence, 57.6% had no change, and 15.9% had a decrease in the probability of recurrence. Among the white men, 13.8% had an increase in the probability of recurrence, 64.5% had no change, and 21.7% had a decrease in the probability of recurrence. Black men were twice as likely to have a significant increase in the probability of recurrence postoperatively compared with white men after adjusting for preoperative prostate-specific antigen level, clinical stage, and biopsy Gleason sum (odds ratio 2.0, 95% confidence interval 1.3-3.1, P = .002). CONCLUSIONS These data could assist clinicians when counseling black men regarding their treatment options according to their preoperative risk profile. UROLOGY 74: 660-664, 2009. (C) 2009 Elsevier Inc.
引用
收藏
页码:660 / 664
页数:5
相关论文
共 50 条
  • [31] Statin use and risk of prostate cancer biochemical recurrence after radical prostatectomy
    Prabhu, Nicole
    Kapur, Navina
    Catalona, William
    Leikin, Robin
    Helenowski, Irene
    Jovanovich, Borko
    Gurley, Michael
    Okwuosa, Tochi M.
    Kuzel, Timothy M.
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2021, 39 (02) : 130.e9 - 130.e15
  • [32] Identification of men with the highest risk of early disease recurrence after radical prostatectomy
    Sundi, Debasish
    Wang, Vinson
    Pierorazio, Phillip M.
    Han, Misop
    Partin, Alan W.
    Tran, Phuoc T.
    Ross, Ashley E.
    Bivalacqua, Trinity J.
    PROSTATE, 2014, 74 (06): : 628 - 636
  • [33] Risk of biochemical recurrence after radical prostatectomy among men using 5α-reductase inhibitors and alpha-blockers
    Murtola, T. J.
    Tammela, T. L. J.
    EUROPEAN UROLOGY SUPPLEMENTS, 2012, 11 (01) : E349 - E349
  • [34] Biochemical Recurrence After Radical Prostatectomy With or Without Pelvic Lymphadenectomy in Korean Men With High-risk Prostate Cancer
    Ku, Ja Hyeon
    Jeong, Chang Wook
    Park, Yong Hyun
    Cho, Min Chul
    Kwak, Cheol
    Kim, Hyeon Hoe
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2011, 41 (05) : 656 - 662
  • [35] ARE EAU RISK GROUPS RELIABLE IN THE STRATIFICATION OF MEN WITH BIOCHEMICAL RECURRENCE AFTER RADICAL PROSTATECTOMY AND RESTAGED WITH PSMA-PET?
    Gandaglia, Giorgio
    Necchi, Andrea
    Raggi, Daniele
    Stabile, Armando
    Cucchiara, Vito
    Mazzone, Elio
    Sorce, Gabriele
    Pellegrino, Francesco
    Scuderi, Simone
    Barletta, Francesco
    Robesti, Daniele
    Pellegrino, Antony
    Quarta, Leonardo
    Zaurito, Paolo
    Zaffuto, Emanuele
    Picchio, Maria
    Gajate, Ana Maria Samanes
    Gianolli, Luigi
    Marra, Giancarlo
    Gontero, Paolo
    Montorsi, Francesco
    Briganti, Alberto
    JOURNAL OF UROLOGY, 2023, 209 : E550 - E550
  • [36] Use of statins and the risk of prostate cancer biochemical recurrence in men treated with radical prostatectomy.
    Trapp, Luke
    Helenowski, Irene B.
    Gurley, Michael
    Leikin, Robin
    Catalona, William
    Jovanovic, Borko
    Kuzel, Timothy
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [37] BIOCHEMICAL RECURRENCE AFTER RADICAL PROSTATECTOMY: WHO IS AT RISK OF DYING FROM PROSTATE CANCER?
    Suardi, Nazareno
    Gandaglia, Giorgio
    Dell'Oglio, Paolo
    Capitanio, Umberto
    Passoni, Niccolo M.
    Bianchi, Marco
    Abdollah, Firas
    Karakiewicz, Pierre
    Shariat, Sharokh
    Guazzoni, Giorgio
    Montorsi, Francesco
    Briganti, Alberto
    JOURNAL OF UROLOGY, 2015, 193 (04): : E1008 - E1008
  • [38] Biopsy Based Proteomic Assay Predicts Risk of Biochemical Recurrence after Radical Prostatectomy
    Saad, Fred
    Latour, Mathieu
    Lattouf, Jean-Baptiste
    Widmer, Hugues
    Zorn, Kevin C.
    Mes-Masson, Anne-Marie
    Ouellet, Veronique
    Saad, Genevieve
    Prakash, Amol
    Choudhury, Sibgat
    Han, Gang
    Karakiewicz, Pierre
    Richie, Jerome P.
    JOURNAL OF UROLOGY, 2017, 197 (04): : 1034 - 1040
  • [39] Characteristics and risk factors of biochemical recurrence after radical prostatectomy in patients with prostate cancer
    Duan, Guanglan
    Wang, Changmei
    Ma, Caihong
    Zhang, Huiming
    Wei, Jinxing
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2017, 10 (03): : 5320 - 5325
  • [40] Overweight and obesity as risk factors for biochemical recurrence of prostate cancer after radical prostatectomy
    Kim, Sung Jin
    Park, Min Uk
    Chae, Han Kyu
    Nam, Wook
    Kim, So Won
    Yu, Hoon
    Kim, Han Gwun
    Kang, Gil Hyun
    Park, Jong Yeon
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2022, 27 (02) : 403 - 410